Stocks like NVST, RS, THG and LNVGY are seeing price strength and have a high chance of carrying the momentum forward.

ALGN's record Clear Aligner growth and global adoption support the bull case, but demand softness and scanner pricing pressure keep investors cautious.

Envista raises 2026 guidance as stronger sales and expanding margins lift earnings, but China pricing, tariffs and a tougher Q4 loom.

Envista’s second quarter results were shaped by balanced growth across all major geographies and a continued focus on operational execution. Management pointed to resilient demand for dental care, especially in consumables and diagnostics, as a stabilizing influence despite macroeconomic uncertainty. CEO Paul Keel highlighted that new product launches in endodontics and orthodontics supported share gains, while margin expansion was driven by manufacturing productivity and cost control initiative

Envista's earnings rebound and raised 2026 guidance strengthen the case, but above-median valuation leaves less room for execution setbacks.

Margins expanded 230 basis points as core growth accelerated.

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

PEG-focused value picks Envista, Sanmina, TAL Education and Avient combine discounted valuations with solid long-term growth prospects.

Four value stocks stand out for low PEG ratios, strong earnings growth prospects and favorable value scores, offering potential beyond traditional P/E screens.

AVT, GEO and NVST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 10, 2026.

Examine the evolution of Envista's (NVST) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

VRT, NVST, and AER it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 10, 2026.

Envista Holdings Corporation recently reported Q2 2026 results showing higher sales of US$730.5 million and net income of US$53.7 million, with earnings per share from continuing operations rising to US$0.33. Alongside these results, Envista completed share repurchases totaling 12,458,894 shares for US$250 million, while also raising its full-year 2026 guidance despite expected pricing pressure in China. Now we will examine how Envista’s raised full-year guidance and earnings momentum...

Envista (NYSE:NVST) reported second-quarter 2026 sales of $731 million, supported by 5% core revenue growth and contributions from foreign exchange and acquisitions that lifted total revenue growth to just over 7%. President and Chief Executive Officer Paul Keel said the company delivered balanced

NVST vs. ABT: Which Stock Is the Better Value Option?

Moby summary of Envista Holdings Corp's Q2 2026 earnings call

Envista Holdings Corp (NVST) delivered 5% core sales growth and raised its full-year 2026 outlook, driven by broad-based segment gains and operational efficiency.

Although the revenue and EPS for Envista (NVST) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Envista (NVST) delivered earnings and revenue surprises of +24.24% and +2.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Dental products company Envista Holdings (NYSE:NVST) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 7.1% year on year to $730.5 million. Its non-GAAP profit of $0.41 per share was 22.1% above analysts’ consensus estimates.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Envista (NVST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Let’s dig into the relative performance of Envista (NYSE:NVST) and its peers as we unravel the now-completed Q1 dental equipment & technology earnings season.